AGC Pharma Chemicals will be attending CPHI North America 2025, taking place from May 20 to 22 at the Pennsylvania Convention Center in Philadelphia. As one of the most influential events for pharmaceutical innovation and outsourcing in the region, the conference is expected to bring together over 3,500 industry professionals and more than 300 exhibitors from across the drug development supply chain.
The event serves as a dynamic platform where pharmaceutical, biopharmaceutical, and CDMO leaders come together to explore challenges and opportunities in drug development, manufacturing innovation, regulatory compliance, and strategic partnerships. CPHI North America is also known for its robust content agenda focused on market trends, digitalization, supply chain resiliency, and specialized manufacturing.
For AGC Pharma Chemicals, this event represents an opportunity to further strengthen its presence in the North American market and showcase its capabilities as a trusted CDMO partner for small molecule APIs, with a particular focus on advanced technologies and scalable solutions for High Potency Active Pharmaceutical Ingredients (HPAPIs).
We will be exhibiting alongside our colleagues from AGC Biologics (Booth 1540), offering a comprehensive overview of the AGC Life Science network’s global capabilities. With more than 60 years of experience and a strong track record in regulatory compliance, our sites in Barcelona and Japan support partners through the entire product lifecycle—from early-phase development to commercial manufacturing.
We look forward to engaging with innovators, procurement leaders, and technical stakeholders, and to contributing to the conversations that are shaping the future of pharmaceutical outsourcing.
For more information about the event, visit CPHI website
